(VIANEWS) – The NASDAQ opens in less than three hours and FibroGen‘s pre-market value is already 6.25% down.

The last session, NASDAQ Composite ended with FibroGen (FGEN) dropping 4.08% to $11.04. NASDAQ Composite jumped 0.5% to $14,897.34, after three sequential sessions in a row of gains, on what was a somewhat positive trend trading session.


Today’s last reported volume for FibroGen is 3110194, 134.31% above its average volume of 1327356.

FibroGen’s last close was $11.51, 79.88% below its 52-week high of $57.21.

FibroGen’s Sales

FibroGen’s sales growth is 201.9% for the present quarter and 13.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 134.3% and positive 39.1% for the next.

FibroGen’s Revenue

Year-on-year quarterly revenue growth declined by 43.2%, now sitting on 171.82M for the twelve trailing months.

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $11.04 at 07:19 EST, way under its 52-week high of $57.21 and way above its 52-week low of $9.88.

FibroGen’s Moving Average

FibroGen’s worth is below its 50-day moving average of $11.16 and way under its 200-day moving average of $18.37.


FibroGen’s last day, last week, and last month’s current volatility was 4.16%, 2.36%, and 3.31%, respectively.

FibroGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.25% (day), 3.40% (last week), and 3.79% (last month), respectively.

More news about FibroGen (FGEN).


Please enter your comment!
Please enter your name here